Lotus Eye Hospital Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Lotus Eye Hospital Q2 results FY27 announcement is the next scheduled earnings event for Lotus Eye Hospital and Institute Ltd., a Coimbatore based chain of specialty eye hospitals offering cataract surgery, refractive laser correction, retina and cornea treatment and optical retail across centres in Tamil Nadu and Kerala. The stock traded at Rs 111.88 on the NSE on 11 September 2026, down 0.99% from the previous close of Rs 113.00, about 24.4% below its 52-week high of Rs 148.00 and 43.3% above its 52-week low of Rs 78.05.

What makes the Lotus Eye Hospital Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 13.04 crore of revenue and a profit of Rs 0.12 crore, while the most recent quarter on record, Q1 FY27, produced Rs 17.06 crore and a profit of Rs 0.61 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Lotus Eye Hospital Q2 Results FY27 Date?

The Lotus Eye Hospital Q2 results date for FY27 is not confirmed. As of 11 September 2026, Lotus Eye Hospital and Institute Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Lotus Eye Hospital Q2 results date becomes public through that filing rather than through any advance announcement.

The Lotus Eye Hospital Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Lotus Eye Hospital and Institute.

Lotus Eye Hospital Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Lotus Eye Hospital Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Lotus Eye Hospital and Institute. The Lotus Eye Hospital Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is revenue, which was Rs 13.04 crore in September 2025, the lowest of the five quarters, against Rs 17.06 crore in Q1 FY27. Sales jumped 25% in June 2026 after four quarters flat in a Rs 13 crore band.

The second is the operating margin, which was 5.90% in September 2025 and 17.29% in Q1 FY27. Margin collapsed to 3.53% by March 2026 and then swung nearly fourteen points in a single quarter, so the June figure is a sharp break from the trend.

The third is whether the company stays profitable. December 2025 and March 2026 were both loss-making at the net level, at Rs 0.26 crore and Rs 0.32 crore, and three consecutive quarters carried negative tax rates including a credit booked on a profitable September 2025.

Check Lotus Eye Hospital and Institute Ltd. Live Fundamentals on the Univest Screener

Lotus Eye Hospital Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Lotus Eye Hospital and Institute Ltd. reported revenue of Rs 17.06 crore in Q1 FY27, up 26.18% from Rs 13.52 crore in Q1 FY26, and a profit of Rs 0.61 crore at the net level, up 12.96% from Rs 0.54 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was up 25.35% over the March 2026 quarter figure of Rs 13.61 crore, and net profit was a swing from a loss of Rs 0.32 crore in Q4 FY26 to a profit of Rs 0.61 crore. Operating margin stood at 17.29% in Q1 FY27 against 5.90% in the September 2025 quarter, which is the comparison the Lotus Eye Hospital Q2 results print will be read against.

Q2 FY26 Base: The Comparison Lotus Eye Hospital Q2 Results FY27 Must Beat

Lotus Eye Hospital and Institute Ltd. reported revenue of Rs 13.04 crore and a profit of Rs 0.12 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Lotus Eye Hospital Q2 results preview.

Net profit in that base quarter was below the Rs 0.61 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 13.04 crore sits below the Rs 17.06 crore of the June 2026 quarter, which frames how much sequential movement the Lotus Eye Hospital Q2 results print needs to show growth.

Lotus Eye Hospital and Institute Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	13.04	0.12
Q3 FY26 (Dec 2025)	13.55	(0.26)
Q4 FY26 (Mar 2026)	13.61	(0.32)
Q1 FY27 (Jun 2026)	17.06	0.61

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Lotus Eye Hospital Q2 results preview uses.

Revenue across those four quarters ranged from Rs 13.04 crore to Rs 17.06 crore, and net profit from Rs 0.32 crore loss to Rs 0.61 crore. That spread is the honest context for the Lotus Eye Hospital Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Lotus Eye Hospital Q2 Results FY27

The Lotus Eye Hospital Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Lotus Eye Hospital and Institute has already reported.

Cataract Volume Drives the Business

Cataract surgery is the largest single procedure by volume at an eye hospital and a substantial share of it is funded through state health schemes, so reimbursement rates and scheme empanelment affect both volume and realisation.

New Capacity Explains the June Step

Depreciation doubled across the window and interest rose more than four times, from Rs 0.12 crore to Rs 0.51 crore, both landing alongside the 25% revenue jump. That combination is consistent with a debt-funded capacity addition now contributing.

The Multiple Rests on Almost No Earnings

A price to earnings ratio of 1,453.44 on trailing earnings per share of Rs 0.08 is arithmetic on a near-zero profit base, with return on equity of 0.13%. Every quarter reconciles exactly, so the figures themselves are clean; it is the earnings base that is tiny.

Lotus Eye Hospital Q2 Results FY27: Share Price and Valuation Going Into the Print

Lotus Eye Hospital and Institute share price today is Rs 111.88 on the NSE, down Rs 1.12 or 0.99% from the previous close of Rs 113.00 on 11 September 2026, ahead of the Lotus Eye Hospital Q2 results announcement.

Metric	Value (11 September 2026)
NSE Symbol	LOTUSEYE
Current Market Price	Rs 111.88
52-Week High	Rs 148.00
52-Week Low	Rs 78.05
Market Capitalisation	Rs 233 crore
PE Ratio	1,453.44
PB Ratio	3.87
EPS (TTM)	Rs 0.08
Book Value per Share	Rs 28.90
Debt to Equity	0.26
Return on Equity	0.13%
50-Day Moving Average	Rs 116.48
200-Day Moving Average	Rs 116.00
RSI (14)	39.43

The stock trades below both its 50-day average of Rs 116.48 and its 200-day average of Rs 116.00, with a 14-day RSI of 39.43. None of this is a view on where the shares go once the Lotus Eye Hospital Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Lotus Eye Hospital and Institute Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Lotus Eye Hospital Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Lotus Eye Hospital Q2 results print in proportion.

1. Revenue against the Rs 13.04 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 0.12 crore in that same quarter
3. Operating margin against 17.29% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Lotus Eye Hospital Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Lotus Eye Hospital Q2 Results FY27

The Lotus Eye Hospital Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Lotus Eye Hospital and Institute Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Lotus Eye Hospital Q2 results FY27 print faces a base of Rs 13.04 crore in revenue and a profit of Rs 0.12 crore, with the most recent quarter having delivered Rs 17.06 crore and a profit of Rs 0.61 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Lotus Eye Hospital and Institute, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Lotus Eye Hospital Q2 Results FY27

What is the Lotus Eye Hospital Q2 results date for FY27?

Ans. The Lotus Eye Hospital Q2 results date for FY27 is not confirmed. Lotus Eye Hospital and Institute Ltd. had not filed a board meeting intimation with the NSE or BSE as of 11 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Lotus Eye Hospital Q2 results 2026 cover?

Ans. The Lotus Eye Hospital Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Lotus Eye Hospital and Institute Ltd. reports revenue, operating profit and net profit for that period, and the Lotus Eye Hospital Q2 results filing also carries the notes to the accounts.

What were the Lotus Eye Hospital and Institute Q1 FY27 results?

Ans. Lotus Eye Hospital and Institute Ltd. reported revenue of Rs 17.06 crore in Q1 FY27 and a profit of Rs 0.61 crore at the net level. Revenue was up 26.18% versus Q1 FY26 and net profit was up 12.96% from Rs 0.54 crore in Q1 FY26.

What were Lotus Eye Hospital and Institute Q2 FY26 results in the September 2025 quarter?

Ans. Lotus Eye Hospital and Institute Ltd. reported revenue of Rs 13.04 crore and a profit of Rs 0.12 crore in Q2 FY26. Operating margin was 5.90%. Those figures form the base for the Lotus Eye Hospital Q2 results FY27 comparison.

What are the main Lotus Eye Hospital Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Lotus Eye Hospital Q2 results expectations centre on revenue against the Rs 13.04 crore base, net profit against a profit of Rs 0.12 crore, operating margin against 17.29% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Lotus Eye Hospital and Institute share price today ahead of the Q2 earnings?

Ans. Lotus Eye Hospital and Institute share price is Rs 111.88 on the NSE as of 11 September 2026, down 0.99% from Rs 113.00. The stock is about 24.4% below its 52-week high of Rs 148.00 and 43.3% above its 52-week low of Rs 78.05, at a market capitalisation of Rs 233 crore.

Is Lotus Eye Hospital and Institute a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Lotus Eye Hospital and Institute Ltd. The stock trades at a price-to-book ratio of 3.87 with a return on equity of 0.13%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.